Mode
Text Size
Log in / Sign up

Kaposi Sarcoma

Part of Epithelioid Sarcoma

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Kaposi Sarcoma

5 trials tracked for Kaposi Sarcoma.

5Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 3 Phase 1 2
  1. Phase 2 Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial. Completed
  2. Phase 2 Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma Completed
  3. Phase 2 Pomalidomide for Kaposi Sarcoma in People With or Without HIV Completed
  4. Phase 1 Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer Completed
  5. Phase 1 An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS) Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Epithelioid Sarcoma

Related studies from across the Epithelioid Sarcoma family.

Interval-compressed VDC/IE protocol feasibility and outcomes in 27 Ewing's sarcoma patients at a North African center
Oncology Cohort
Interval-compressed VDC/IE protocol feasibility and outcomes in 27 Ewing's sarcoma patients at a North African center Compressed chemotherapy showed mixed results for Ewing's sarcoma patients in a small study.
This retrospective, single-institutional cohort study evaluated an interval-compressed VDC/IE protocol in 27 patients with Ewing's sarcoma t…
A small study found that a compressed chemotherapy regimen for Ewing's sarcoma had high toxicity and low survival rates.
Protocol for a systematic review and network meta-analysis of second-line soft tissue sarcoma treatments
Oncology Meta-analysis
Protocol for a systematic review and network meta-analysis of second-line soft tissue sarcoma treatments Protocol outlines options for second-line soft tissue sarcoma treatments
This is a protocol for a systematic review and network meta-analysis. It will evaluate second-line pharmacological regimens for advanced sof…
A new protocol maps second-line drug choices for advanced soft tissue sarcoma patients previously treated with anthracyclines, noting curren…
Post-hoc analysis suggests regional hyperthermia plus chemotherapy may improve survival in extremity soft tissue sarcoma
Oncology RCT
Post-hoc analysis suggests regional hyperthermia plus chemotherapy may improve survival in extremity soft tissue sarcoma Adding heat to chemo may improve survival for soft-tissue sarcoma patients
This post-hoc analysis of a randomized trial examined overall survival in patients with extremity soft tissue sarcoma receiving neoadjuvant …
A post-hoc analysis of a randomized trial suggests adding regional hyperthermia to chemotherapy improved survival for patients with extremit…
mGPS associated with survival in advanced soft tissue sarcoma patients receiving trabectedin treatment in retrospective analysis
Oncology Cohort
mGPS associated with survival in advanced soft tissue sarcoma patients receiving trabectedin treatment in retrospective analysis Blood Work May Predict Who Benefits From Sarcoma Drug
This retrospective cohort study evaluated 60 patients with advanced soft tissue sarcoma treated with trabectedin across multiple tertiary on…
A simple blood test score could help doctors predict how long patients live after starting a specific sarcoma treatment.
Retrospective cohort study assesses delta-NLR and baseline NLR for prognosis in soft tissue sarcoma
Oncology Cohort
Retrospective cohort study assesses delta-NLR and baseline NLR for prognosis in soft tissue sarcoma A Simple Blood Test Change Could Predict Survival in Sarcoma
This retrospective cohort study included 231 patients with soft tissue sarcoma.
Watching how a blood marker changes during treatment may give sarcoma patients a clearer picture of their future.
Case report finds West Nile virus encephalitis in immunocompromised child after transfusions
Infectious Disease Cohort
Case report finds West Nile virus encephalitis in immunocompromised child after transfusions Case report links West Nile virus infection to blood transfusions in Saudi Arabia
A case report with cross-sectional donor screening describes a 4-year-old Saudi girl with Ewing's sarcoma who developed WNV encephalitis aft…
A 4-year-old Saudi girl with cancer developed a serious brain infection after receiving blood transfusions, highlighting risks for vulnerabl…
Case report describes diagnostic challenges in bilateral epithelioid sarcoma of the thigh
Oncology Sys. Review
Case report describes diagnostic challenges in bilateral epithelioid sarcoma of the thigh Imaging tests missed rare cancer in woman with thigh tumors, case report shows
A case report and literature review describes a 47-year-old woman with bilateral thigh masses where ultrasonography and MRI failed to provid…
Common scans missed a rare cancer in a woman with thigh tumors, proving that biopsies are vital when imaging results are unclear.

Questions about Kaposi Sarcoma

Can Pomalyst be used to treat Kaposi sarcoma in addition to Multiple Myeloma?

Yes, Pomalyst is FDA-approved for both multiple myeloma and Kaposi sarcoma, including AIDS-related and HIV-negative cases.

Full answer →